Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2018 March;43(1) > Minerva Endocrinologica 2018 March;43(1):37-49

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW  THE EVOLUTION OF IVF 

Minerva Endocrinologica 2018 March;43(1):37-49

DOI: 10.23736/S0391-1977.17.02636-0

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Controlled ovarian stimulation and triggers in in vitro fertilization: protocol personalization key to optimize outcomes

Jacqueline Y. MAHER, Mindy S. CHRISTIANSON

Division of Reproductive Endocrinology and Infertility, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA


PDF


The past four decades have delivered many advancements to improve in vitro fertilization (IVF) outcomes. These include a delicate balance of controlled ovarian hyperstimulation (COH) without causing ovarian hyperstimulation syndrome (OHSS), a safe oocyte retrieval, fertilization and embryo culture, endometrial growth and receptivity to promote implantation, and luteal support to maintain the pregnancy. Contemporary IVF practice includes both the classic COH protocols as well as protocols for poor responders and those for specific patient populations. An assortment of agents have been developed and utilized in various combinations to improve COH outcomes and promote oocyte maturation while decreasing the risk of OHSS. Various protocols have evolved over time. Ideal practices involve selecting the optimal protocol for a personalized, patient-specific stimulation and trigger.


KEY WORDS: Fertilization in vitro - Ovulation induction - Gonadotropins - Menotropins - Leuprolide - Letrozole

top of page